Literature DB >> 17493018

Mucosal and peripheral immune responses to chlamydial heat shock proteins in women infected with Chlamydia trachomatis.

T Agrawal1, V Vats, S Salhan, A Mittal.   

Abstract

Most of the studies on 60-kDa and 10-kDa chlamydial heat shock proteins (HSPs) to date have been carried out with blood lymphocytes or serum antibody responses, which do not provide a clear picture of the actual pathogenesis as they do not differentiate primary infection from recurrent infection. Thus, in the present study induction of the immune response was evaluated by studying lymphoproliferation of both cervical and peripheral lymphocytes to synthetic peptides of cHSP60, cHSP10 and major outer membrane protein (MOMP) antigen. In addition, cervical antibody prevalence to MOMP antigen, cHSP60 and cHSP10 and cytokine levels in cervical washes was also determined. Positive proliferative responses of cervical lymphocytes to cHSP10 peptide were significantly higher (P < 0.05) in women with recurrent infections and that to MOMP antigen were significantly higher in primary infection. On proliferation of PBMCs with the above antigens, no significant difference was observed between primary and recurrent infection. Prevalence of cervical IgG and IgA antibodies to Chlamydia trachomatis was significantly higher (P < 0.05) during primary infection than recurrent infections. In contrast, prevalence of IgG and IgA antibodies to cHSP10 and IgG antibodies to cHSP60 was higher during recurrent infections than primary infections. Interferon (IFN)-gamma levels were significantly higher in cervical washes of women with recurrent infection and correlated strongly with cHSP60 antibody titres. Our data thus suggest that mucosal responses are more appropriate in understanding the pathogenesis of chlamydial infection and IFN-gamma could be involved in the modulation of immune responses towards chlamydial infection directly, by causing acute inflammation, or indirectly through modulation of HSP expression.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17493018      PMCID: PMC1941927          DOI: 10.1111/j.1365-2249.2007.03357.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  30 in total

Review 1.  Global epidemiology of sexually transmitted diseases.

Authors:  A C Gerbase; J T Rowley; T E Mertens
Journal:  Lancet       Date:  1998       Impact factor: 79.321

Review 2.  The heat-shock proteins.

Authors:  S Lindquist; E A Craig
Journal:  Annu Rev Genet       Date:  1988       Impact factor: 16.830

3.  Previously undetected Chlamydia trachomatis infection, immunity to heat shock proteins and tubal occlusion in women undergoing in-vitro fertilization.

Authors:  S D Spandorfer; A Neuer; D LaVerda; G Byrne; H C Liu; Z Rosenwaks; S S Witkin
Journal:  Hum Reprod       Date:  1999-01       Impact factor: 6.918

4.  Predominance of Chlamydia trachomatis serovars associated with urogenital infections in females in New Delhi, India.

Authors:  Vineeta Singh; Sudha Salhan; B C Das; A Mittal
Journal:  J Clin Microbiol       Date:  2003-06       Impact factor: 5.948

5.  Combined detection of Chlamydia trachomatis-specific antibodies against the 10 and 60-kDa heat shock proteins as a diagnostic tool for tubal factor infertility: Results from a case-control study in Cameroon.

Authors:  Innocenti Dadamessi; François Eb; Fotini Betsou
Journal:  FEMS Immunol Med Microbiol       Date:  2005-02-10

6.  Demonstration of delayed hypersensitivity in Chlamydia trachomatis salpingitis in monkeys: a pathogenic mechanism of tubal damage.

Authors:  D L Patton; Y T Sweeney; C C Kuo
Journal:  J Infect Dis       Date:  1994-03       Impact factor: 5.226

7.  Morphologic and antigenic characterization of interferon gamma-mediated persistent Chlamydia trachomatis infection in vitro.

Authors:  W L Beatty; G I Byrne; R P Morrison
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

8.  Cloning and sequence of the gene for heat shock protein 60 from Chlamydia trachomatis and immunological reactivity of the protein.

Authors:  M C Cerrone; J J Ma; R S Stephens
Journal:  Infect Immun       Date:  1991-01       Impact factor: 3.441

9.  Subjects recovering from human ocular chlamydial infection have enhanced lymphoproliferative responses to chlamydial antigens compared with those of persistently diseased controls.

Authors:  R L Bailey; M J Holland; H C Whittle; D C Mabey
Journal:  Infect Immun       Date:  1995-02       Impact factor: 3.441

10.  Chlamydia trachomatis Infection, Immunity, and Pregnancy Outcome.

Authors:  S S Witkin; A Neuer; P Giraldo; J Jeremias; V Tolbert; I L Korneeva; D Kneissl; A M Bongiovanni
Journal:  Infect Dis Obstet Gynecol       Date:  1997
View more
  10 in total

1.  Differential profiles of immune mediators and in vitro HIV infectivity between endocervical and vaginal secretions from women with Chlamydia trachomatis infection: a pilot study.

Authors:  Rhoda Sperling; Thomas A Kraus; Jian Ding; Alina Veretennikova; Elizabeth Lorde-Rollins; Tricia Singh; Yungtai Lo; Alison J Quayle; Theresa L Chang
Journal:  J Reprod Immunol       Date:  2013-08-08       Impact factor: 4.054

Review 2.  Human and Pathogen Factors Associated with Chlamydia trachomatis-Related Infertility in Women.

Authors:  S Menon; P Timms; J A Allan; K Alexander; L Rombauts; P Horner; M Keltz; J Hocking; W M Huston
Journal:  Clin Microbiol Rev       Date:  2015-10       Impact factor: 26.132

3.  Diversity of Cervicovaginal Cytokine Response to Incident Chlamydia trachomatis Infection Among a Prospective Cohort of Young Women.

Authors:  Loris Y Hwang; Mark E Scott; Yifei Ma; Anna-Barbara Moscicki
Journal:  Am J Reprod Immunol       Date:  2015-05-20       Impact factor: 3.886

Review 4.  Chlamydia trachomatis vaccine research through the years.

Authors:  Katelijn Schautteet; Evelien De Clercq; Daisy Vanrompay
Journal:  Infect Dis Obstet Gynecol       Date:  2011-06-26

5.  Immunopathogenesis in Chlamydia trachomatis Infected Women.

Authors:  Maria Teresa Mascellino; Priscilla Boccia; Alessandra Oliva
Journal:  ISRN Obstet Gynecol       Date:  2011-11-24

6.  Chlamydia trachomatis Antibody Testing in Vaginal Mucosal Material versus Blood Samples of Women Attending a Fertility Clinic and an STI Clinic.

Authors:  Ingrid V F van den Broek; Jolande A Land; Jan E A M van Bergen; Servaas A Morré; Marianne A B van der Sande
Journal:  Obstet Gynecol Int       Date:  2014-03-13

7.  Modulation of cytokines and transcription factors (T-Bet and GATA3) in CD4 enriched cervical cells of Chlamydia trachomatis infected fertile and infertile women upon stimulation with chlamydial inclusion membrane proteins B and C.

Authors:  Rishein Gupta; Harsh Vardhan; Pragya Srivastava; Sudha Salhan; Aruna Mittal
Journal:  Reprod Biol Endocrinol       Date:  2009-08-22       Impact factor: 5.211

8.  Host immune responses to chlamydial inclusion membrane proteins B and C in Chlamydia trachomatis infected women with or without fertility disorders.

Authors:  Rishein Gupta; Pragya Srivastava; Harsh Vardhan; Sudha Salhan; Aruna Mittal
Journal:  Reprod Biol Endocrinol       Date:  2009-04-28       Impact factor: 5.211

9.  In infertile women, cells from Chlamydia trachomatis infected sites release higher levels of interferon-gamma, interleukin-10 and tumor necrosis factor-alpha upon heat-shock-protein stimulation than fertile women.

Authors:  Pragya Srivastava; Rajneesh Jha; Sylvette Bas; Sudha Salhan; Aruna Mittal
Journal:  Reprod Biol Endocrinol       Date:  2008-05-20       Impact factor: 5.211

Review 10.  Immunity, immunopathology, and human vaccine development against sexually transmitted Chlamydia trachomatis.

Authors:  Jose Rey-Ladino; Allen G P Ross; Allan W Cripps
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.